Hou XY - Search Results

1

Recent developments in nanomedicine for melanoma treatment.

Tang JQ, Hou XY, Yang CS, Li YX, Xin Y, Guo WW, Wei ZP, Liu YQ, Jiang G. Tang JQ, et al. Among authors: hou xy. Int J Cancer. 2017 Aug 15;141(4):646-653. doi: 10.1002/ijc.30708. Epub 2017 Apr 6. Int J Cancer. 2017. PMID: 28340496 Free article. Review.

2

NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion.

Liu Y, Zhang G, Gao C, Hou X. Liu Y, et al. Brain Res. 2001 Aug 3;909(1-2):51-8. doi: 10.1016/s0006-8993(01)02619-1. Brain Res. 2001. PMID: 11478920

3

Temozolomide for Treating Malignant Melanoma.

Li RH, Hou XY, Yang CS, Liu WL, Tang JQ, Liu YQ, Jiang G. Li RH, et al. Among authors: hou xy. J Coll Physicians Surg Pak. 2015 Sep;25(9):680-8. J Coll Physicians Surg Pak. 2015. PMID: 26374366 Review.

4

DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines.

Chen YP, Hou XY, Yang CS, Jiang XX, Yang M, Xu XF, Feng SX, Liu YQ, Jiang G. Chen YP, et al. Among authors: hou xy. Tumour Biol. 2016 Aug;37(8):11209-18. doi: 10.1007/s13277-016-4994-1. Epub 2016 Mar 4. Tumour Biol. 2016. PMID: 26943799

5

Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.

Hou XY, Jiang G, Yang CS, Tang JQ, Wei ZP, Liu YQ. Hou XY, et al. Recent Pat Anticancer Drug Discov. 2016;11(3):322-31. doi: 10.2174/1574892811666160309121035. Recent Pat Anticancer Drug Discov. 2016. PMID: 26955964 Review.

6

Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.

Xin Y, Huang Q, Zhang P, Yang M, Hou XY, Tang JQ, Zhang LZ, Jiang G. Xin Y, et al. Among authors: hou xy. Medicine (Baltimore). 2016 Apr;95(16):e3406. doi: 10.1097/MD.0000000000003406. Medicine (Baltimore). 2016. PMID: 27100429 Free PMC article. Review.

7

Nanoscale drug delivery for targeted chemotherapy.

Xin Y, Huang Q, Tang JQ, Hou XY, Zhang P, Zhang LZ, Jiang G. Xin Y, et al. Among authors: hou xy. Cancer Lett. 2016 Aug 28;379(1):24-31. doi: 10.1016/j.canlet.2016.05.023. Epub 2016 May 25. Cancer Lett. 2016. PMID: 27235607 Review.

8

Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.

Jiang G, Li R, Tang J, Ma Y, Hou X, Yang C, Guo W, Xin Y, Liu Y. Jiang G, et al. Oncol Rep. 2017 Feb;37(2):995-1001. doi: 10.3892/or.2016.5342. Epub 2016 Dec 29. Oncol Rep. 2017. PMID: 28035395

9

Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy.

Hou X, Zhou H, Wang L, Tang J, Chen C, Jiang G, Liu Y. Hou X, et al. Cancer Lett. 2017 Apr 1;390:168-175. doi: 10.1016/j.canlet.2016.12.026. Epub 2016 Dec 29. Cancer Lett. 2017. PMID: 28040545

10

Enhanced anti-tumor efficacy of temozolomide-loaded carboxylated poly(amido-amine) combined with photothermal/photodynamic therapy for melanoma treatment.

Tang J, Zhou H, Hou X, Wang L, Li Y, Pang Y, Chen C, Jiang G, Liu Y. Tang J, et al. Cancer Lett. 2018 Jun 1;423:16-26. doi: 10.1016/j.canlet.2018.03.002. Epub 2018 Mar 7. Cancer Lett. 2018. PMID: 29524557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

267 results

Search Page